141 related articles for article (PubMed ID: 1781471)
1. Inability to justify a part-time clinical pharmacist in a community hospital intensive-care unit.
Rosenbaum CL; Fant WK; Miyagawa CI; Armitstead JA
Am J Hosp Pharm; 1991 Oct; 48(10):2154-7. PubMed ID: 1781471
[TBL] [Abstract][Full Text] [Related]
2. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
Chuang LC; Sutton JD; Henderson GT
Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
[TBL] [Abstract][Full Text] [Related]
3. Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit.
Miyagawa CI; Rivera JO
Am J Hosp Pharm; 1986 Dec; 43(12):3008-13. PubMed ID: 3812508
[TBL] [Abstract][Full Text] [Related]
4. Using clinical interventions to cost-justify additional pharmacy staff.
Catania HF; Catania PN
Hosp Pharm; 1988 Jun; 23(6):544, 546-8. PubMed ID: 10312548
[TBL] [Abstract][Full Text] [Related]
5. Effect of a pharmacist's and a nurse's interventions on cost of drug therapy in a medical intensive-care unit.
Katona BG; Ayd PR; Walters JK; Caspi M; Finkelstein BW
Am J Hosp Pharm; 1989 Jun; 46(6):1179-82. PubMed ID: 2750769
[TBL] [Abstract][Full Text] [Related]
6. The economic impact of clinical pharmacists' unsolicited recommendations.
Torok N; Brown G
Hosp Pharm; 1992 Dec; 27(12):1052-3, 1056-8, 1060. PubMed ID: 10122507
[TBL] [Abstract][Full Text] [Related]
7. Documentation of cost savings from decentralized clinical pharmacy services at a community hospital.
Taylor JT; Kathman MS
Am J Hosp Pharm; 1991 Jul; 48(7):1467-70. PubMed ID: 1882875
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the impact of a clinical pharmacist on the quality and cost of pharmacotherapy in a general surgical department, the Hillel-Yaffe Medical Center].
Schwartzberg E; Livny S; Sterenberg A; Troitsa A; Oren M; Shani S
Harefuah; 2003 Jan; 142(1):5-9, 80. PubMed ID: 12647481
[TBL] [Abstract][Full Text] [Related]
9. Documentation of the first steps of pediatric pharmaceutical care in a county hospital.
Lal LS; Anassi EO; McCants E
Hosp Pharm; 1995 Dec; 30(12):1107-8, 1111-2. PubMed ID: 10153657
[TBL] [Abstract][Full Text] [Related]
10. Benefits of clinical pharmacy services in a community hospital.
Williams LE
Hosp Pharm; 1993 Aug; 28(8):759-63, 766-7. PubMed ID: 10127576
[TBL] [Abstract][Full Text] [Related]
11. Implementation of pharmaceutical care in acute medical cardiovascular patients.
Chisholm MA; Pittman DG; Longley JM; Mullis SR
Hosp Pharm; 1995 Jul; 30(7):572-4, 577-8. PubMed ID: 10144212
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
[TBL] [Abstract][Full Text] [Related]
13. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
MacLaren R; Bond CA
Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
[TBL] [Abstract][Full Text] [Related]
14. Four years' experience with a clinical intervention program: cost avoidance and impact of a clinical coordinator.
Catania HF; Yee WP; Catania PN
Am J Hosp Pharm; 1990 Dec; 47(12):2701-5. PubMed ID: 2278286
[TBL] [Abstract][Full Text] [Related]
15. Obtaining a critical care pharmacist position: a marketing case study.
Stratton TP; Wu B; Nakagawa RS
Can J Hosp Pharm; 1993 Jun; 46(3):109-14. PubMed ID: 10126865
[TBL] [Abstract][Full Text] [Related]
16. Using serum creatinine concentrations to screen for inappropriate dosage of renally eliminated drugs.
Peterson JP; Colucci VJ; Schiff SE
Am J Hosp Pharm; 1991 Sep; 48(9):1962-4. PubMed ID: 1928141
[TBL] [Abstract][Full Text] [Related]
17. An analysis of pharmacist interventions.
Torchinsky A; Landry D
Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
[TBL] [Abstract][Full Text] [Related]
18. ASHP national survey of hospital-based pharmaceutical services--1992.
Crawford SY; Myers CE
Am J Hosp Pharm; 1993 Jul; 50(7):1371-404. PubMed ID: 8362870
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of a clinical pharmacist on a neurosurgical team.
Weant KA; Armitstead JA; Ladha AM; Sasaki-Adams D; Hadar EJ; Ewend MG
Neurosurgery; 2009 Nov; 65(5):946-50; discussion 950-1. PubMed ID: 19834408
[TBL] [Abstract][Full Text] [Related]
20. Culture and antibiotic monitoring service in a community hospital.
Von Seggern RL
Am J Hosp Pharm; 1987 Jun; 44(6):1358-62. PubMed ID: 3303924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
